These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25952485)

  • 1. Optimal post-treatment surveillance in cancer survivors: is more really better?
    Shah M; Denlinger CS
    Oncology (Williston Park); 2015 Apr; 29(4):230-40. PubMed ID: 25952485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise in cancer survivors: an overview of research.
    Courneya KS
    Med Sci Sports Exerc; 2003 Nov; 35(11):1846-52. PubMed ID: 14600549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caring for the life you saved.
    Beck AC; Mooney K
    Oncology (Williston Park); 2015 Apr; 29(4):240-8. PubMed ID: 25952486
    [No Abstract]   [Full Text] [Related]  

  • 5. Surveillance approaches among colorectal cancer survivors after curative-intent.
    Haggstrom DA; Imperiale TF
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):483-500. PubMed ID: 19942831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance and monitoring of adult cancer survivors.
    Choi M; Craft B; Geraci SA
    Am J Med; 2011 Jul; 124(7):598-601. PubMed ID: 21683826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surviving surveillance.
    Sweetenham JW
    Oncology (Williston Park); 2015 Apr; 29(4):228. PubMed ID: 25952484
    [No Abstract]   [Full Text] [Related]  

  • 8. Costs of different follow-up strategies in early breast cancer: a review of the literature.
    van Hezewijk M; van den Akker ME; van de Velde CJ; Scholten AN; Hille ET
    Breast; 2012 Dec; 21(6):693-700. PubMed ID: 23084960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up care for cancer: making the benefits equal the cost.
    Schwartz D; Billingsley K; Wallner K
    Oncology (Williston Park); 2000 Oct; 14(10):1493-8, 1501; discussion 1502-5. PubMed ID: 11098513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II.
    Blanchard CM; Courneya KS; Stein K;
    J Clin Oncol; 2008 May; 26(13):2198-204. PubMed ID: 18445845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New analysis reexamines the value of cancer care in the United States compared to Western Europe.
    Soneji S; Yang J
    Health Aff (Millwood); 2015 Mar; 34(3):390-7. PubMed ID: 25732488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.
    Zheng Z; Yabroff KR; Guy GP; Han X; Li C; Banegas MP; Ekwueme DU; Jemal A
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26705361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement.
    Meyerhardt JA; Mangu PB; Flynn PJ; Korde L; Loprinzi CL; Minsky BD; Petrelli NJ; Ryan K; Schrag DH; Wong SL; Benson AB;
    J Clin Oncol; 2013 Dec; 31(35):4465-70. PubMed ID: 24220554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization.
    Gatta G; Trama A; Capocaccia R
    J Natl Cancer Inst Monogr; 2013; 2013(46):79-87. PubMed ID: 23962511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active surveillance for prostate cancer: progress and promise.
    Cooperberg MR; Carroll PR; Klotz L
    J Clin Oncol; 2011 Sep; 29(27):3669-76. PubMed ID: 21825257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
    Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
    Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance to family practice of English-language guidelines on breast, colorectal and prostate cancer: a review.
    Dahlhaus A; Semlitsch T; Jeitler K; Horvath K; Siebenhofer A
    Fam Pract; 2015 Oct; 32(5):483-91. PubMed ID: 26142418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data.
    Hall PS; Hamilton P; Hulme CT; Meads DM; Jones H; Newsham A; Marti J; Smith AF; Mason H; Velikova G; Ashley L; Wright P
    Br J Cancer; 2015 Mar; 112(5):948-56. PubMed ID: 25602964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic disparities in treatment costs among ambulatory Medicaid cancer patients.
    Mullins CD; Snyder SE; Wang J; Cooke JL; Baquet C
    J Natl Med Assoc; 2004 Dec; 96(12):1565-74. PubMed ID: 15622686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.